Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.19 USD | +3.45% | -4.19% | -4.97% |
Jul. 01 | Akero Therapeutics, Inc.(NasdaqGS:AKRO) added to Russell Small Cap Comp Value Index | CI |
Jul. 01 | Akero Therapeutics, Inc.(NasdaqGS:AKRO) added to Russell 3000 Value Index | CI |
Business Summary
Number of employees: 59
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jonathan Young
FOU | Founder | 54 | 17-03-31 |
Timothy Rolph
FOU | Founder | 70 | 17-03-31 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 18-08-31 |
William White
DFI | Director of Finance/CFO | 51 | 19-03-31 |
Chief Tech/Sci/R&D Officer | - | 20-11-30 | |
Investor Relations Contact | - | - | |
Libette Luce
LAW | General Counsel | - | 22-04-30 |
Patrick Lamy
PRN | Corporate Officer/Principal | 51 | 22-12-31 |
Kitty Yale
PRN | Corporate Officer/Principal | 52 | 18-09-30 |
Arindam Bose
PRN | Corporate Officer/Principal | 71 | 18-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Seth Harrison
BRD | Director/Board Member | 63 | 16-12-31 |
Jane Henderson
BRD | Director/Board Member | 58 | 19-04-22 |
Mark Iwicki
CHM | Chairman | 57 | 18-10-31 |
Andrew Cheng
CEO | Chief Executive Officer | 57 | 18-08-31 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 20-06-08 |
Jonathan Young
FOU | Founder | 54 | 17-03-31 |
Judy Chou
BRD | Director/Board Member | 58 | 21-07-11 |
Graham Walmsley
BRD | Director/Board Member | 37 | 18-05-31 |
Yuan Xu
BRD | Director/Board Member | 56 | 21-04-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 69,151,007 | 58,792,395 ( 85.02 %) | 0 | 85.02 % |
Company contact information
Akero Therapeutics, Inc.
601 Gateway Boulevard Suite 350
94080-7006, South San Francisco
+650 487 6488
http://www.akerotx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.97% | 1.53B | |
+18.43% | 124B | |
+19.81% | 114B | |
-23.74% | 19.42B | |
-18.45% | 16.2B | |
-19.97% | 15.31B | |
-49.33% | 14.19B | |
+57.08% | 14.32B | |
+7.95% | 14.31B | |
+126.04% | 11.29B |
- Stock Market
- Equities
- AKRO Stock
- Company Akero Therapeutics, Inc.